Literature DB >> 32345337

Is a more aggressive COVID-19 case detection approach mitigating the burden on ICUs? Some reflections from Italy.

Giulia Lorenzoni1, Corrado Lanera1, Danila Azzolina1,2, Paola Berchialla3, Dario Gregori4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32345337      PMCID: PMC7186947          DOI: 10.1186/s13054-020-02881-y

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
Italy is the first European country in which the COVID-19 epidemic outbreak has spread, starting from two regions in Northern Italy, Veneto, and Lombardia. The outbreak poses a relevant burden on hospital resources, with a marked increase in the intensive care unit (ICU) occupancy rates [1]. It has been hypothesized that the proportion of severe infections that need intensive care could be affected by the testing strategy. At the beginning of the epidemic outbreak (21 February), an extensive testing strategy of both symptomatic and asymptomatic subjects has been adopted in Veneto and Lombardia. However, soon after the starting of the outbreak (27 February), the Italian Ministry of Health introduced restrictions in testing asymptomatic/mild symptomatic subjects. Such a recommendation has been a topic of debate among Italian scientists and policymakers since it has been suggested that also asymptomatic patients seem to transmit the infection [2]. For this reason, different strategies have been adopted at the regional level, thanks to the local autonomy of the regional health services. The Lombardia region adopted the recommendation [1], while the Veneto region did not apply the restrictions in testing asymptomatic/mild symptomatic patients [3], in line with the strategy adopted by the Republic of Korea. To compare such two testing strategies, we assessed the relationship between the percentage of ICU admissions on the resident population and the percentage of asymptomatic/mild symptomatic subjects tested on the resident population, in Lombardia and Veneto. Analyses are based on official data [4]. The asymptomatic/mild symptomatic subjects tested were obtained by subtracting the daily number of newly hospitalized patients from the total number of tests performed on the same day. The choice of asymptomatic patients instead of the overall number of patients was performed to avoid artifactual collinearity in the two dimensions being analyzed. Smoothing approximation using a loess regression method using polynomials of degree 2 with the alpha parameter set to 1.5 [5] has been fitted. The results are reported in Fig. 1. At the beginning of the observation (24 February), the percentage of asymptomatic/mild symptomatic subjects tested was 0.014% in Lombardia and 0.044% in Veneto, with 0.00019% and 0.00008% admissions in ICU in Lombardia and Veneto, respectively. At the 27th of March, the asymptomatic/mild symptomatic subjects tested were 0.83% in Lombardia and 1.66% in Veneto, with 0.01283% and 0.00689% of subjects admitted to the ICU in Lombardia and Veneto, respectively. Such data show a higher percentage of asymptomatic/mild symptomatic subjects tested since the beginning of the outbreak in Veneto, corresponding to a lower percentage of subjects admitted to the ICU.
Fig. 1

The x-axis reports the percentage (%) of subjects not hospitalized who underwent COVID-19 testing; the x-axis reports the percentage (%) of subjects admitted to the ICU (calculated on resident population). The continuous line indicates the local polynomial regression fitting; the dotted line shows the observed percentages

The x-axis reports the percentage (%) of subjects not hospitalized who underwent COVID-19 testing; the x-axis reports the percentage (%) of subjects admitted to the ICU (calculated on resident population). The continuous line indicates the local polynomial regression fitting; the dotted line shows the observed percentages These findings suggest that testing also asymptomatic/mild symptomatic patients would help reduce the proportion of most severe cases eventually requiring ICU and thus limiting the risk of saturation of ICU units.
  2 in total

1.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.

Authors:  Giacomo Grasselli; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

2.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

  2 in total
  9 in total

1.  Predicting in-Hospital Mortality of Patients with COVID-19 Using Machine Learning Techniques.

Authors:  Fabiana Tezza; Giulia Lorenzoni; Danila Azzolina; Sofia Barbar; Lucia Anna Carmela Leone; Dario Gregori
Journal:  J Pers Med       Date:  2021-04-24

2.  Regional Differences in Mortality Rates During the COVID-19 Epidemic in Italy.

Authors:  Danila Azzolina; Giulia Lorenzoni; Luciano Silvestri; Ilaria Prosepe; Paola Berchialla; Dario Gregori
Journal:  Disaster Med Public Health Prep       Date:  2020-12-22       Impact factor: 1.385

3.  How Large Was the Mortality Increase Directly and Indirectly Caused by the COVID-19 Epidemic? An Analysis on All-Causes Mortality Data in Italy.

Authors:  Corrado Magnani; Danila Azzolina; Elisa Gallo; Daniela Ferrante; Dario Gregori
Journal:  Int J Environ Res Public Health       Date:  2020-05-15       Impact factor: 3.390

4.  A first estimation of the impact of public health actions against COVID-19 in Veneto (Italy).

Authors:  Dario Gregori; Danila Azzolina; Corrado Lanera; Ilaria Prosepe; Nicolas Destro; Giulia Lorenzoni; Paola Berchialla
Journal:  J Epidemiol Community Health       Date:  2020-05-04       Impact factor: 3.710

5.  Effects of environmental parameters and their interactions on the spreading of SARS-CoV-2 in North Italy under different social restrictions. A new approach based on multivariate analysis.

Authors:  Fabio Tateo; Sirio Fiorino; Luca Peruzzo; Maddalena Zippi; Dario De Biase; Federico Lari; Dora Melucci
Journal:  Environ Res       Date:  2022-02-10       Impact factor: 8.431

6.  Impact of the COVID-19 lockdown on psychological health and nutritional habits in Italy: results from the #PRESTOinsieme study.

Authors:  Giulia Lorenzoni; Danila Azzolina; Elisabetta Maresio; Silvia Gallipoli; Marco Ghidina; Solidea Baldas; Paola Berchialla; Maria Cecilia Giron; Marco Silano; Dario Gregori
Journal:  BMJ Open       Date:  2022-04-05       Impact factor: 3.006

7.  Analysis of the Fatality Rate in Relation to Testing Capacity during the First 50 days of the COVID-19 Epidemic in Italy.

Authors:  Costanza Vicentini; Stefano Bazzolo; Dario Gamba; Carla Maria Zotti
Journal:  Am J Trop Med Hyg       Date:  2020-10-15       Impact factor: 3.707

8.  A Web-Based Application to Monitor and Inform about the COVID-19 Outbreak in Italy: The {COVID-19ita} Initiative.

Authors:  Corrado Lanera; Danila Azzolina; Francesco Pirotti; Ilaria Prosepe; Giulia Lorenzoni; Paola Berchialla; Dario Gregori
Journal:  Healthcare (Basel)       Date:  2022-03-03

9.  Editorial: Diagnostic Testing for SARS-Coronavirus-2 in the Nursing Facility: Recommendations of a Delphi Panel of Long-Term Care Clinicians.

Authors:  M Wasserman; J G Ouslander; A Lam; A G Wolk; J E Morley; S von Preyss-Friedman; N Marco; A Nazir; D Haimowitz; F Bessey
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.